Explicit Finance (530571)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trading at ₹5.91 against book value of ₹9.63, a P/B of 0.61, gives a 39% discount to stated net worth.
• Latest quarter is roughly break-even, not loss-making, with net profit at ₹0 Cr.
• Profit growth of 87.50% shows some recent earnings improvement, albeit from a low base.
• Piotroski F-Score of 5/9 indicates passable financial health, not a deeply distressed score.

Concerns

• P/E of 84.36 is extremely rich; the 87.50% profit growth is low-base distortion and earnings may not be sustainable.
• Sales declined 27.64%; latest quarter sales are only ₹1 Cr, indicating a shrinking franchise.
• ROCE of -0.13% and ROE of 1.40% mean the company is not earning a satisfactory return on capital or equity.
• Current price is below the 52-week low of ₹6.50, there is no dividend, and promoter holding is not disclosed—weak signals for minority investors.

AI Analysis

At ₹5.91, Explicit Finance is a ₹6 crore microcap, exactly the kind of stock I generally avoid unless there is a clear margin of safety. The first thing I see is a price-to-book of 0.61 against book value of ₹9.63, so on a liquidation basis the market is offering a discount. But a discount to book is only meaningful if the assets earn an acceptable return. Here ROE is just 1.40% and ROCE is negative at -0.13%; this is not a good business, it is a mediocre capital allocator. Sales fell 27.64%, and the latest quarter shows only ₹1 crore in sales and roughly zero net profit. The reported 87.50% profit growth is from a low base and cannot justify a P/E of 84.36. The company has no dividend and no promoter holding data, which raises governance and transparency concerns. The Piotroski F-score of 5 out of 9 is middling—no evidence of a fundamental turnaround. The 52-week range has the stock trading below its own low, which tells me there is no support. In Graham's terms, the book value provides a possible asset cushion, but with negative ROCE and shrinking revenue, I am buying a business that is not earning its keep. I would call this an asset play, not a quality compounder. Value investing is not about buying cheap statistics; it is about buying a good business at a fair price. Here I have a weak business at a cheap multiple. I would need to see stable sales, positive returns, or a true catalyst before deploying even a small amount of capital.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer